Delivery Order SPE2DB24D2003-SPE2DB24FXFL6

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The order, valued at $1,212.62, is for the supply of SUNOSI 150 MG TABLET 30S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of Sunosi 75 mg tablets, a prescription medication, with a ceiling value of $2,283.30 and a completion date of July 9, 2024. The contract is a firm fixed-price delivery order without a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen, a major pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,600.17 for the supply of Sunosi 150 mg tablets. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of Amerisourcebergen. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which enables the agency to efficiently procure a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Sunosi 150 mg tablets. The $2,139.76 firm fixed-price contract does not have a set-aside designation and has an ultimate completion date of August 19, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Sunosi 150 mg tablets to the government. The firm-fixed-price delivery order, valued at $1,796.57, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 4, 2024 and was awarded on November 1, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The order, valued at $3,314.95, is for the supply of 75 mg SUNOSI tablets (national stock number 4565618399). The award has a firm fixed price and the ultimate completion date is August 29, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,369.99 firm fixed price contract is for the supply of Sunosi 75 mg tablets to support military healthcare programs. The contract has a period of performance through January 31, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the supply of SUNOSI 75 mg tablets, a specialty pharmaceutical product. The completion date for this delivery order is February 1, 2024, and the potential value is $2,456.97. This delivery order is not designated as a set-aside contract....
This $1,299.54 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 75mg Sunosi tablets to support federal healthcare programs. The award has an ultimate completion date of July 24, 2024 and there is no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts with DLA and other agencies, valued up to $999,999,999 and $750,000 respectively,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of SUNOSI 150 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,357.03 and a performance period ending on July 3, 2025. This contract is not set aside and was awarded on a firm-fixed-price basis. AmerisourceBergen Drug Corp is the prime contractor for this...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB24FXFL6
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $2,424.61 fixed-price contract is for the delivery of Sunosi 150 mg tablets, a prescription medication. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract has no set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market.

Generated 10/8/24, 9:02 AM